These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12751766)

  • 21. Enantiospecific, selective cyclooxygenase-2 inhibitors.
    Kozak KR; Prusakiewicz JJ; Rowlinson SW; Marnett LJ
    Bioorg Med Chem Lett; 2002 May; 12(9):1315-8. PubMed ID: 11965379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure.
    Okada K; Yuhi T; Tsuji S; Yamashita U
    Brain Res; 2001 Mar; 894(2):332-5. PubMed ID: 11251211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress in the study of cyclooxygenase].
    Zhu H; Yang ZM
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs.
    Black SC; Brideau C; Cirino M; Belley M; Bosquet J; Chan CC; Rodger IW
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):686-94. PubMed ID: 9821840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cyclooxygenase-substrate interactions using stereospecifically-labeled arachidonic acids.
    Schneider C; Boeglin WE; Brash AR
    Adv Exp Med Biol; 2002; 507():49-53. PubMed ID: 12664563
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible inconsistencies in study on cyclooxygenase.
    Kay-Mugford T; Conlon P
    Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
    [No Abstract]   [Full Text] [Related]  

  • 28. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
    Marnett LJ; Rowlinson SW; Goodwin DC; Kalgutkar AS; Lanzo CA
    J Biol Chem; 1999 Aug; 274(33):22903-6. PubMed ID: 10438452
    [No Abstract]   [Full Text] [Related]  

  • 29. [COX-2 inhibitors: current status and outlook].
    Dannhardt G; Hahn L
    Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
    [No Abstract]   [Full Text] [Related]  

  • 30. [COX-2 inhibition: latest on NSAID].
    Z Orthop Ihre Grenzgeb; 1997; 135(1):Oa20-1. PubMed ID: 9199064
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmacologic closure of the patent ductus arteriosus.
    Van Overmeire B; Chemtob S
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):177-84. PubMed ID: 15701582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
    Vanegas H
    Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
    [No Abstract]   [Full Text] [Related]  

  • 33. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Closing in on a stomach-sparing aspirin substitute.
    Service RF
    Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
    [No Abstract]   [Full Text] [Related]  

  • 35. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    Feldman M; McMahon AT
    Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
    [No Abstract]   [Full Text] [Related]  

  • 36. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 38. Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors.
    Shahbazian A; Schuligoi R; Heinemann A; Peskar BA; Holzer P
    Br J Pharmacol; 2001 Mar; 132(6):1299-309. PubMed ID: 11250881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Topical pharmacology. COX-2 inhibitors].
    Heinzl S
    Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
    [No Abstract]   [Full Text] [Related]  

  • 40. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.